Lonza Group AG
LONN
Rank in Stocks
#449
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Share Price
$761.37
Market Cap
$53.18B
Change (1 day)
0.61%
Change (1 year)
8.22%
Country
CH
Trade Lonza Group AG (LONN)
Category
Healthcare
Operating Margin for Lonza Group AG (LONN)
Operating Margin as of 2026 TTM: 0.00%
According to Lonza Group AG latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Lonza Group AG from 2004 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 21.16% | 44.34% |
| 2024 | 14.66% | 11.91% |
| 2023 | 13.10% | -47.09% |
| 2022 | 24.76% | 57.41% |
| 2021 | 15.73% | -24.34% |
| 2020 | 20.79% | -4.72% |
| 2019 | 21.82% | 19.76% |
| 2018 | 18.22% | 0.94% |
| 2017 | 18.05% | 20.90% |
| 2016 | 14.93% | 14.06% |
| 2015 | 13.09% | 6.86% |
| 2014 | 12.25% | 7.36% |
| 2013 | 11.41% | 33.61% |
| 2012 | 8.54% | -11.96% |
| 2011 | 9.70% | -30.52% |
| 2010 | 13.96% | 57.21% |
| 2009 | 8.88% | -40.88% |
| 2008 | 15.02% | 5.63% |
| 2007 | 14.22% | 7.97% |
| 2006 | 13.17% | 11.80% |
| 2005 | 11.78% | 21.82% |
| 2004 | 9.67% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 28.81% | - |
NL
|
|
| 31.23% | - |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.